Amicus Therapeutics Inc (NASDAQ:FOLD)

10.96
Delayed Data
As of Mar 27
 +0.29 / +2.72%
Today’s Change
1.77
Today|||52-Week Range
13.20
+31.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues456.0K475.0K293.0K0.00
 
 
 
 
Depreciation And Amortization412.0K396.0K375.0K363.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------363.0K
 
 
General Expenses15.2M14.7M17.3M21.1M
 
 
 
 
 
Research And Development10.0M10.0M12.0M15.6M
 
 
 
 
 
Total Operating Expenses15.6M15.1M17.7M21.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.1M-14.7M-17.4M-21.5M
 
 
 
 
 
Extraordinary Credit8.0K386.0K600.0K--
 
 
 
 
Extraordinary Charge-514.0K-10.0K-26.0K-511.0K
 
 
 
 
 
Interest Expense On Debt355.0K374.0K377.0K378.0K
 
 
 
 
 
Other Expenses0.000.000.00-47.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.9M-14.6M-17.1M-22.3M
 
 
 
 
 
Income Taxes0.000.000.00-1.1M
 
 
Net Income-15.9M-14.6M-17.1M-21.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS64.4M67.2M78.9M87.0M
 
 
 
 
 
Shares To Calculate EPS Diluted64.4M67.2M78.9M87.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.22-$0.22-$0.24
 
 
 
 
 
EPS Diluted-$0.25-$0.22-$0.22-$0.24
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account